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SYNOPSIS 
Mitochondria are essential eukaryotic organelles, acting as the sites for numerous crucial 
metabolic and signalling pathways. The biogenesis of mitochondria requires efficient 
targeting of several hundreds of proteins from the cytosol, to their varied functional 
locations within the organelle. The translocation of localized proteins across the inner 
membrane, and their subsequent folding is achieved by the ATP-dependent function of 
mitochondrial Hsp70 (mtHsp70). It is a bonafide member of the Hsp70 chaperone 
family, which are involved in a multitude of functions, together aimed at protein quality 
control and maintenance of cellular homeostasis. These varied functions of Hsp70 
proteins require binding to exposed hydrophobic patches in substrate polypeptides thus 
preventing non-productive associations. The interaction with substrates occurs through 
the substrate-binding domain (SBD) and is regulated by the ATPase activity of the 
nucleotide-binding domain (NBD), through a series of conformational changes. 
Conversely, substrate binding to the SBD also stimulates ATP hydrolysis, and thereby 
the core activities of the two domains are regulated by mutual allosteric signalling. This 
mechanism of bidirectional inter-domain communication is indispensable for Hsp70 
function, which is characterized by cycles of substrate binding and release, coupled to 
cycles of ATP binding and hydrolysis. The process of allosteric regulation in Hsp70 
proteins has been comprehensively investigated, especially in the bacterial homolog, 
DnaK. However, the in vivo functional significance of inter-domain communication in 
the eukaryotic mtHsp70 system and the mechanism of its regulation remain unexplored. 
Furthermore, the complex physiological implications of impairment in allosteric 
communication and their correlation with diverse disease conditions, including 
Myelodysplastic syndrome (MDS), and Parkinson’s disease (PD), are yet to be 
elucidated.    
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 Based on this brief introduction, the primary research objectives set out in the present thesis 
were to: 
1. uncover the regulation of ligand-modulated allosteric communication between the two 
domains of mtHsp70; and its in vivo significance in the context of protein import into the 
organelle.  (Chapter 2) 
2. understand the role of mtHsp70 in progression of Parkinson’s disease; and to study the 
modulation of α-synuclein toxicity by the protein quality control function of the mtHsp70 
chaperone network. (Chapters 3 and 4) 
We have employed a battery of genetic and biochemical approaches to investigate 
the above questions using the Saccharomyces cerevisiae mtHsp70 protein, Ssc1; an 
essential protein that is involved in a plethora of critical functions in this eukaryotic model 
system.    
Objective 1: Structural studies, primarily in bacterial DnaK, have yielded mechanistic 
insights into its interactions with ligands and cochaperones, as well as conformational 
transitions in different ligand-bound states.  In recent years, the availability of crystal 
structures of full-length DnaK and detailed information from NMR studies and single-
molecule resolution spectroscopic analyses (both DnaK and eukaryotic Hsp70s), have 
significantly contributed to our understanding of the inter-domain interface, critical residues 
and contacts, and the energetics of the entire process of ligand-modulated conformational 
changes. Although eukaryotic mtHsp70s have a high degree of conservation with DnaK, 
they possess significant differences in their conformational and biochemical properties. 
They are essential for a vast repertoire of physiological functions, which are distinctly 
different from their bacterial counterpart. Using a combined in vivo and in vitro approach, 
we have uncovered specific structural elements within mtHsp70s, which are required for 
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allosteric modulation of the chaperone cycle and maintenance of in vivo functions of the 
protein. Foremost, we demonstrate that a conserved SBD loop, L4,5  plays a critical role in 
inter-domain communication, and multiple mutations in this loop result in significant 
growth and protein translocation defects. The mutants are associated with a specific set of 
altered biochemical properties, which are indicative of impaired inter-domain 
communication. Using the loop L4,5 mutant, E467A as a template for genetic screening, we 
report a series of intragenic suppressor mutations, which are capable of correcting a distinct 
subset of the altered properties, and thereby leading to restoration of in vivo functions, 
including growth, preprotein import and mitochondria biogenesis. The suppressors modify 
the altered conformational landscape associated with E467A, and also provide us with 
information regarding unique aspects governing the regulation of allosteric communication, 
especially in physiological contexts. Strikingly, they reveal that restoration of 
communication in the NBD to SBD direction is sufficient for function, when the protein is 
primed in a high ATPase activity state. In this unique scenario, the requirement for ATPase 
stimulation upon substrate binding is rendered unnecessary, thereby making conformational 
changes in the SBD to NBD direction, dispensable for function. Further, we provide 
evidence to show that loop L4,5 functions synergistically with the linker region, working in 
tandem for organization of  the inter-domain interface and propagation of communication. 
Together, our analyses provide the first insights into regulation of allosteric inter-domain 
communication in vivo and their implications in mitochondrial protein translocation and 
organelle biogenesis.  
 
Objective 2: Point mutations in the loop L4,5 have been associated with Myelodysplastic 
syndrome. Additionally, a mutation isolated in clinical cases of Parkinson’s disease was 
found to be impaired in allosteric communication. These observations further highlight the 
importance of efficient inter-domain communication in mtHsp70 in the complex 
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physiological scenario of eukaryotic cells. Independent clinical screens of PD patients have 
revealed unique point mutations in the mtHsp70 and a strong association of the gene locus 
with the disease progression. This is also correlated with decreased mtHsp70 levels in 
affected neurons and the interactions of this protein with established PD-candidate proteins 
like α-synuclein and Dj-1.  Further, mitochondrial dysfunction is a common phenomenon 
associated with neurodegenerative disorders. To understand the specific role of mtHsp70 in 
PD, we have developed a yeast model for studying the disease variants in isolation from 
other players of the multifactorial disease, and in complete absence of the wild type protein. 
We generated two analogous PD-mutations in Ssc1, R103W and P486S; which 
recapitulated the symptoms of mitochondrial dysfunction in affected neurons, including cell 
death, inner membrane depolarization, increased generation of ROS, and respiratory 
incompetence. At the molecular level, we observed an increased aggregation propensity of 
R103W, while P486S exhibited futile enhanced interaction with J-protein cochaperone 
partners thereby resulting in loss of chaperoning activity and impaired mitochondrial 
protein quality control. Remarkably, these altered biochemical properties mimicked similar 
defects in the human mtHsp70 variants, therefore, affirming the involvement of mtHsp70 in 
PD progression.   
To further investigate the relevance of impaired mitochondrial protein quality 
control in PD, we have explored whether mtHsp70 can act as a genetic modifier of α-
synuclein toxicity. It is known that α-synuclein can act as an unfolded substrate for the 
Hsp70 chaperone system and also deposits as intracellular aggregates in PD-affected brains. 
Intriguingly, it is known to translocate into mitochondria under conditions of neuronal 
stress in spite of lacking a canonical mitochondrial signal sequence. Utilizing our yeast-PD 
model, we find that targeting of α-synuclein A30P disease variant into mitochondria leads 
to a severe mitochondrial dysfunction phenotype in the wild type Ssc1 background, but not 
the P486S mutant background. This results in multiple cellular manifestations, which are 
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reversed upon overexpression of the Ssc1 chaperone. Significantly, increasing the J-protein 
cochaperone availability also leads to reversal of the mutant-associated defects. However, 
the simultaneous overexpression of both together does not additively improve the protective 
effects; highlighting the importance of the relative availability of chaperone and 
cochaperone proteins in preventing aggregation. Our analyses further reveal that while both 
the wild type and P486S Ssc1 proteins are equally capable of delaying aggregation of α-
synuclein, only the wild-type chaperone is better able to prevent aggregation in the 
presence of its J-protein cochaperone, leading to accumulation of soluble oligomeric 
species. These observations raised the intriguing possibility, that the reduced chaperoning 
ability of the proline to serine PD-mutant is, in fact, a compensatory adaptation, favoring 
the aggregation of α-synuclein over its more toxic soluble oligomeric form.  We verify this 
hypothesis with the aggregation kinetics of A30P α-synuclein, whose intrinsically lower 
aggregation tendency results in a pronounced delay in aggregation with the wild-type 
chaperone, thereby strongly favoring the toxic oligomeric species and correlating with the 
observed lethality in yeast cells. In conclusion, our study provides a model of α-synuclein 
aggregation-related toxicity and its modulation by the extent of protein quality control 
within the mitochondrial matrix, through the action of the mtHsp70 chaperone network.  
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